# Hypofractionated Radiochemotherapy

> **NCT06331468** · PHASE2 · RECRUITING · sponsor: **Denise Fabian** · enrollment: 20 (estimated)

## Conditions studied

- Uterine Cervix Cancer

## Interventions

- **DRUG:** Cisplatin
- **RADIATION:** intensity modulated radiation therapy (IMRT)
- **RADIATION:** high-dose-rate (HDR) brachytherapy

## Key facts

- **NCT ID:** NCT06331468
- **Lead sponsor:** Denise Fabian
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-26
- **Primary completion:** 2026-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06331468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06331468, "Hypofractionated Radiochemotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06331468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*